Home AdAlta

AdAlta

In operation
IPO
Clinical-stage biotechnology R&D provider
Basic
Enterprise Profile

Basic Information

AdAlta is an innovative clinical-stage biotechnology company developing a range of unique new drug therapies. Utilizing its i-body platform to discover and develop the next generation of protein therapies, addressing drug targets that are challenging for other technologies.
AdAlta Pty Ltd
Victoria,Australia
less than 15 people
January 01, 2010
enquiries@adalta.com.au

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Technology
Protein Technology
Concept
Therapeutic Products
Application Scenarios
Innovative Drugs